GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HitGen Inc (SHSE:688222) » Definitions » Growth Rank

HitGen (SHSE:688222) Growth Rank : 0 (As of Jun. 20, 2024)


View and export this data going back to 2020. Start your Free Trial

What is HitGen Growth Rank?

HitGen has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

HitGen Growth Rank Related Terms

Thank you for viewing the detailed overview of HitGen's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

HitGen (SHSE:688222) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HitGen Inc (SHSE:688222) » Definitions » Growth Rank
Comparable Companies
SHSE:688293 SHSE:688513 SHSE:603590 SHSE:688238 SHSE:688197 SHSE:600200 SHSE:688046 SZSE:300497 SHSE:603566 SZSE:301333 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 18, Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093
Website
https://www.hitgen.com
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

HitGen (SHSE:688222) Headlines

No Headlines